An open-label, multi-center, multiple application study of naftifine HCl gel 2% (Naftin) in pediatric patients with tinea pedis.
Phase of Trial: Phase II
Latest Information Update: 31 Mar 2015
At a glance
- Drugs Naftifine (Primary)
- Indications Tinea pedis
- Focus Therapeutic Use
- 31 Mar 2015 New trial record
- 20 Mar 2015 According to Merz Pharma media release, results from this study will be presented at the Annual Meeting of the American Academy of Dermatology.